Latest Conference Articles

Pharmacy Times will be covering the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting live in Chicago, Illinois, from June 3 through 7, 2022.

We're rowing in the same direction as pharmacists, so that what is of interest to a payer, PBMs and pharmacies, according to PQA.

We spoke with Kelly McAuliff, PharmD, BCOP, CSP, to learn about data being presented at the ASCO 2022 Annual Meeting.

Just making sure that everybody has a seat at the table is the most important thing at PQA.

PQA wants to expand the types of services covered and report on the results of the current examples that are profiled in the SDOH guide.

The challenges in pharmacy are really a lack of standardization.

Pharmacists are ideally positioned to screen patients for estimation aids and then refer them to services.

Pharmacists are an important touch point for PQA, and they're starting small and thinking big.

PQA is also committed to national goals related to HIV and reducing HIV ending the epidemic.

PQA is focused on actually testing the feasibility and implementation of some of these measures as concepts.

One example that has already been done in the past relates to understanding how to better measure insulin persistence.

Issues like medication access and transportation cost all impact a patient's ability to have access to medications and use them safely and effectively.

It's really opening up the world for pharmacists to develop more meaningful measures and get at patient reported and clinical outcome measures.

It's extremely important for pharmacists to be involved in helping care for people who have HIV.

Pharmacy performance measures allow the pharmacy to be more engaged in the patient's care that focuses on outcomes.

There are many initiatives that are going on at PQA right now that are related to health equity.

The guide is an opportunity to just catalog what else is going on there to kind of be an inspiration for expansion of services.

The goals of the pharmacy measures are ultimately to be used in value based arrangements.

There are other courses available on HIV, but PQA's surveys the 13 medication related quality measures out there for HIV.

The term "value" is used interchangeably across our healthcare system.

One of PQA's quantitative research projects that they are working on now is looking at how medication adherence is related to outcomes.

PQA's program is focused on quality measurement and improving the safe and appropriate use of medications.

PQA is working on developing measures specifically for evaluating pharmacy performance measurement.

Neil Lund, senior advisor, Avelere Health and Ryan Urgo, managing director, Health Policy, Avelere Health, discuss the impact of President Biden’s health care agenda on the pharmacy field.

Doug Long, vice president, Industry Relations, IQVIA, discusses notable trends reshaping specialty pharmaceutical channels and the impact of these developments on the role of the pharmacist in the health care team.

The SDOH resource guide focuses on services specific to the pharmacy and pharmacists.

The PQA team is diverse, and they have expertise in quantitative research as well as quality.

These measures are specified for application to pharmacies, as opposed to health plan measures.

Ray Tancredi, divisional vice president of Specialty Pharmacy, Development & Brand Rx/Vaccine Purchasing at Walgreens, discusses blockbuster drugs in the oncology space that have been approved this year or may be hitting the market soon.

Tracy Russell, senior director, State Government Affairs at CoverMyMeds, discusses state and federal legislation that may be impacting the future of specialty pharmacies and the patient care they deliver.